imi Care
  • Home
  • Project
    • Context
    • Objectives & Strategy
    • Expected Results
  • Consortium
  • Clinical trial platform
    • Structure & services
    • Platform partner profiles
    • Patient information
  • News
  • Press/Publications
  • Resources
  • Contact

Pages

 

  • Clinical trial platform
  • Consortium
  • Contact
  • Credits
  • Home
  • Legal Notice
  • News
  • Press/Publications
  • Privacy Policy
  • Project
  • Resources
  • Sitemap

News

 

  • Category: News
    • White paper published: High throughput cryo-electron microscopy epitope mapping of SARS-CoV-2 spike protein antibodies
    • Published in Nature Communications: Mechanism of AT-527 presents as a promising research avenue against COVID-19
    • The faces behind the CARE work-packages – WP3
    • The faces behind the CARE work-packages – WP2
    • The faces behind the CARE work-packages – WP1
    • CARE paper published in JCIM: Modeling of protein-small molecule complexes with HADDOCK
    • CARE paper published in Journal of Virology: New insights for assessment of SARS-CoV-2 infection estimates and (vaccine-induced) antibody durability response
    • CARE paper published in Science Translational Medicine: New cell-free assay
    • CARE paper published in Circulation: Mechanisms of SARS-CoV-2 with regards to endothelial cells
    • CARE paper published in iScience: CD177 is associated with coronavirus disease 2019 severity and death
    • CARE paper published in Nature: HCQ use against SARS-CoV-2 infection
    • Repurposing efforts concluded
    • CARE scientists identified a SARS-CoV-2 neutralizing antibody with activity against all known variants of concern
    • One Year of CARE Against COVID-19
    • One Year of CARE Against COVID-19
    • One Year of CARE Against COVID-19
    • Survey on GDPR and eConsent during the COVID-19 pandemic
    • Mention of CARE in Le Monde
    • EMA – ITF collaboration
    • IMI Press release
    • CARE Press release
    • CARE Kick-off meeting week
    • Start of the CARE project

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005077. The JU receives support from the European Union’s Horizon 2020 research and innovation programme, EFPIA, BILL & MELINDA GATES FOUNDATION, GLOBAL HEALTH DRUG DISCOVERY INSTITUTE and UNIVERSITY OF DUNDEE.

Logos Partenaires
Menu
  • Home
  • Project
  • Consortium
  • News
  • Press/Publications
  • Resources
  • Contact
Information
  • Legal Notice
  • Sitemap
  • Credits
  • RSS Feed
imi-care
www.imi-care.eu
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
These cookies are not mandatory but will help us upgrade your visit:

- Google Analytics : Website statistics
SAVE & ACCEPT